Solara Active Pharma Sciences Q3 FY24 results: loss at ₹275.34Cr, Revenue decreased by 36.99% YoY
Solara Active Pharma Sciences Q3 FY24 results: Revenue decreased by 36.99% YoY & loss at ₹275.34Cr
Solara Active Pharma Sciences declared their Q3 FY24 results on 14 Feb, 2024. The topline decreased by 36.99% & the loss came at ₹275.34cr. It is noteworthy that Solara Active Pharma Sciences had declared a profit of ₹0.45cr in the previous fiscal year same period. As compared to the previous quarter, the revenue declined by 41.51%.
The Selling, general & administrative expenses declined by 2.31% q-o-q & increased by 7.17% Y-o-Y.
The operating income was down by 4139.03% q-o-q & decreased by 1571.33% Y-o-Y.
The EPS is ₹-59.05 for Q3 FY24, which decreased by 49310.31% Y-o-Y.
Solara Active Pharma Sciences has delivered -1.46% return in the last 1 week, 5.76% return in the last 6 months, and 8.46% YTD return.
Currently, Solara Active Pharma Sciences has a market cap of ₹1409.97 Cr and a 52wk high/low of ₹449.8 & ₹286 respectively.
As of 17 Feb, 2024, out of 2 analysts covering the company, 1 analyst has given a Strong Sell rating & 1 analyst has given a Strong Buy rating.
Solara Active Pharma Sciences Financials
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 248.73 | 425.24 | -41.51% | 394.75 | -36.99% |
| Selling/ General/ Admin Expenses Total | 62.64 | 64.12 | -2.31% | 58.45 | +7.17% |
| Depreciation/ Amortization | 25.96 | 26.21 | -0.95% | 27.98 | -7.22% |
| Total Operating Expense | 499.15 | 419.04 | +19.12% | 377.73 | +32.14% |
| Operating Income | -250.42 | 6.2 | -4139.03% | 17.02 | -1571.33% |
| Net Income Before Taxes | -275.34 | -17.06 | -1513.95% | 0.55 | -50161.82% |
| Net Income | -275.34 | -17.16 | -1504.55% | 0.45 | -61286.67% |
| Diluted Normalized EPS | -59.05 | -3.32 | -1679.23% | 0.12 | -49310.31% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.